Aduro Biotech (ADRO) Reports Q2 Loss of $0.50

Aduro Biotech (NASDAQ: ADRO) reported Q2 EPS of ($0.50), versus ($12.27) reported last year. Revenue for the quarter came in at $9.9 million, versus $1 million reported last year.

For earnings history and earnings-related data on Aduro Biotech (ADRO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c